83 related articles for article (PubMed ID: 1173465)
1. Total body irradiation in lymphosarcoma.
Qasim MM
Radiol Clin (Basel); 1975; 44(3):205-9. PubMed ID: 1173465
[TBL] [Abstract][Full Text] [Related]
2. Total body irradiation in non-Hodgkin lymphoma.
Qasim MM
Strahlentherapie; 1975 Apr; 149(4):364-7. PubMed ID: 1094593
[TBL] [Abstract][Full Text] [Related]
3. Involved field radiation, fractionated total body irradiation, high dose cyclophosphamide, and autologous bone marrow transplantation in the treatment of malignant lymphomas.
Ghalie R; Richman CM; Adler SS; Korenblit AD; Kramer TS; Manson S; Dolce A; Kaizer H
Bone Marrow Transplant; 1991 Jul; 8(1):41-5. PubMed ID: 1912954
[TBL] [Abstract][Full Text] [Related]
4. [Twice daily irradiation of nasopharyngeal lymphosarcomas and cancer].
Aliev BM; Chuĭkina NA; Dubinin AV
Med Radiol (Mosk); 1983 Sep; 28(9):13-7. PubMed ID: 6688647
[TBL] [Abstract][Full Text] [Related]
5. Spontaneous remission of aplastic anemia: a retrospective analysis.
Lee JH; Lee JH; Shin YR; Lee JS; Kim WK; Chi HS; Park CJ; Lee KH
Haematologica; 2001 Sep; 86(9):928-33. PubMed ID: 11532620
[TBL] [Abstract][Full Text] [Related]
6. Outcome of hyperfractionated radiotherapy in chemotherapy-resistant non-Hodgkin's lymphoma.
Martens C; Hodgson DC; Wells WA; Sun A; Bezjak A; Pintilie M; Crump M; Gospodarowicz MK; Tsang R
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1183-7. PubMed ID: 16376490
[TBL] [Abstract][Full Text] [Related]
7. Primary non-Hodgkin's lymphoma of the bone: treatment and analysis of prognostic factors for Stage I and Stage II.
Barbieri E; Cammelli S; Mauro F; Perini F; Cazzola A; Neri S; Bunkheila F; Ferrari S; Brandoli V; Zinzani P; Mercuri M; Bacci G
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):760-4. PubMed ID: 15183479
[TBL] [Abstract][Full Text] [Related]
8. [Clinical picture and treatment of recurrent lymphosarcomas after radiotherapy].
Kruglova GV; Pendkharkar DIa
Ter Arkh; 1985; 57(5):110-4. PubMed ID: 3839603
[TBL] [Abstract][Full Text] [Related]
9. Total-body irradiation in advanced lymphosarcoma.
van Dijk-Milatz A
Br J Radiol; 1979 Jul; 52(619):568-70. PubMed ID: 111751
[TBL] [Abstract][Full Text] [Related]
10. [Clinical characteristics and treatment of midline nasal and nasal type NK/T cell lymphoma].
Yong W; Zheng W; Zhang Y
Zhonghua Yi Xue Za Zhi; 2001 Jul; 81(13):773-5. PubMed ID: 11798962
[TBL] [Abstract][Full Text] [Related]
11. [Scintigraphic follow-up studies following cobalt 60 irradiation of liver tumors].
Brase A; Bockslaff H; Kaumann M
Strahlentherapie; 1972 Feb; 143(2):179-85. PubMed ID: 5068150
[No Abstract] [Full Text] [Related]
12. [Primary non-Hodgkin's malignant lymphoma of bone in 5 patients].
Wang Y; Cai R; Wang G
Zhonghua Wai Ke Za Zhi; 1995 Feb; 33(2):86-8. PubMed ID: 7656711
[TBL] [Abstract][Full Text] [Related]
13. Long-term disease-free survival of patients with advanced mantle-cell lymphoma following high-dose chemotherapy.
Kröger N; Hoffknecht M; Dreger P; Krüger W; Zeller W; Krüll A; Stockschläder M; Bittner S; Weh HJ; Zander AR
Bone Marrow Transplant; 1998 Jan; 21(1):55-7. PubMed ID: 9486495
[TBL] [Abstract][Full Text] [Related]
14. [Lymphosarcomas and reticulosarcomas of the upper aerodigestive tract. Natural history and results of radiotherapy].
Brugère J; Schleinger M; Gérard-Marchant R; Tubiana M; Pouillart P; Cachin Y
Bull Cancer; 1974; 61(1):79-92. PubMed ID: 4617613
[No Abstract] [Full Text] [Related]
15. [Half-body irradiation and drug-resistant non-Hodgkin's lymphomas. Apropos of 9 cases].
Touboul E; Béral HM; Raphaël M; Buscaill A; Dominique S; Guérin RA
Bull Cancer; 1987; 74(2):159-65. PubMed ID: 3607298
[TBL] [Abstract][Full Text] [Related]
16. Expectation of aplastic anemia following radiotherapy for malignancy.
Kitabatake T; Sakai K; Saito A
Radiology; 1978 Oct; 129(1):169-71. PubMed ID: 693871
[TBL] [Abstract][Full Text] [Related]
17. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
[TBL] [Abstract][Full Text] [Related]
18. Value of radiation therapy in the management of chemoresistant intermediate grade non-Hodgkin's lymphoma.
Aref A; Narayan S; Tekyi-Mensah S; Varterasian M; Dan M; Eilender D; Karanes C; al-Katib A
Radiat Oncol Investig; 1999; 7(3):186-91. PubMed ID: 10406061
[TBL] [Abstract][Full Text] [Related]
19. Indolent stage IE non-Hodgkin's lymphoma of the orbit: results after primary radiotherapy.
Bischof M; Zierhut D; Neuhof D; Karagiozidis M; Treiber M; Roeder F; Debus J; Krempien R
Ophthalmologica; 2007; 221(5):348-52. PubMed ID: 17728558
[TBL] [Abstract][Full Text] [Related]
20. Primary non-Hodgkin's lymphoma of the CNS treated with CHOD/BVAM or BVAM chemotherapy before radiotherapy: long-term survival and prognostic factors.
Bessell EM; Graus F; Lopez-Guillermo A; Lewis SA; Villa S; Verger E; Petit J
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):501-8. PubMed ID: 15145169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
